Symposium - European Medical Journal

Continue

Symposiums

hematology 8.1 featured image
Hematology
10 Mins
30 Jul 2020

Outcomes for Patients with High-Risk Acute Myeloid Leukaemia: Can We Move from Months to Years?

This symposium focussed on the recognition of, and treatment options for, high-risk AML. Prof Cluzeau considered universal or targeted treatment…
AGILE: Phase III, Double-Blind, Randomised, Placebo-Controlled Study
Hematology
2 Mins
30 Jul 2020

AGILE: Phase III, Double-Blind, Randomised, Placebo-Controlled Study of Ivosidenib in Combination with Azacitidine in Adults with Newly Diagnosed Acute Myeloid Leukaemia and an IDH1 Mutation

Isocitrate dehydrogenase 1 (IDH1) is a metabolic enzyme which catalyses the oxidative decarboxylation of isocitrate to α-ketoglutarate…
Phase Ib/II Study of the IDH1-Mutant Inhibitor Ivosidenib
Hematology
3 Mins
30 Jul 2020

Phase Ib/II Study of the IDH1-Mutant Inhibitor Ivosidenib, with the BCL2-Inhibitor Venetoclax +/-Azacitidine in IDH1-Mutated Myeloid Malignancies

Venetoclax is a potent, selective, oral inhibitor of B-cell lymphoma-2. It is approved in the USA in combination with azacitidine, decitabine…
Rheumatology
12 Mins
28 Jul 2020

Raising the Bar for Optimal Management of Axial Spondyloarthritis

Dr Proft opened the symposium with the case of a 33-year-old female patient referred via the online self-referral tool ‘Bechterew Check’…
Allergy & Immunology
8 Mins
28 Jul 2020

Breakthrough in the Understanding of the Anti-IgE Pathway in Chronic Spontaneous Urticaria and the Potential of Ligelizumab

CSU is the sudden, spontaneous appearance of itchy wheals (hives), angioedema, or both in the absence of specific external stimuli, for >6 weeks…
Allergy & Immunology
10 Mins
28 Jul 2020

New Advances in the Prevention and Management of Food Allergy

Guidelines for the prevention of food allergy have evolved significantly over the last two decades. The definition of an infant at high risk of food…
Rheumatology
10 Mins
21 Jul 2020

Advancing the Treatment of Psoriatic Arthritis: Focus on the IL-23 Pathway

This Janssen-sponsored live symposium “Advancing the Treatment of PsA: Focus on the IL-23 Pathway,” took place virtually at the European League Against…
Rheumatology
15 Mins
21 Jul 2020

In Darwin’s Footsteps: Adaptation Through Innovation in Rheumatoid Arthritis

Prof Schett opened the session by explaining the overall theme and objectives of the symposium. Charles Darwin famously visited the Galápagos islands…